Keyphrases
Novel Therapeutics
100%
Neuroblastoma
100%
Targeted Treatment
100%
Pediatric Cancer
100%
Replication Stress
100%
Replication Stress Response
100%
Cancer Inhibition
100%
CHK1 Inhibitor
75%
Therapeutic Target
50%
Pediatric
50%
Therapeutic Combinations
50%
Children with Cancer
50%
Pediatric Malignancy
50%
Chromosome 11q
50%
Clinical Trials
25%
Anticancer Drugs
25%
Tumor
25%
Drug Target
25%
Therapeutic Approaches
25%
Potential Therapeutics
25%
Vulnerability
25%
Paucity
25%
Clinical Applicability
25%
Clinical High Risk
25%
Preclinical Development
25%
Toxic Side Effects
25%
Practical Applicability
25%
Malignancy
25%
Therapy Resistance
25%
Tumor Subtype
25%
Small Molecule Inhibitors
25%
Less Toxic
25%
Dive
25%
Long-term Health Effects
25%
Potential Biomarkers
25%
Sympathetic Nervous System
25%
Hemizygous
25%
Neuroblastoma Tumor
25%
Chromosomal Aberrations
25%
Chemotherapy Treatment
25%
Cancer Subtypes
25%
Clinical Relapse
25%
MYCN-amplified Neuroblastoma
25%
MYCN Amplification
25%
Somatic mutation
25%
Inhibitor Sensitivity
25%
Treatment Resistance
25%
Checkpoint Kinase 1 (CHK1)
25%
Review Methodology
25%
Hesitancy
25%
Therapeutic Biomarkers
25%
Biomarker Combination
25%
Target Biomarker
25%
Loss Amplification
25%
High-risk Neuroblastoma
25%
Treatment Therapy
25%
Extracranial Solid Tumors
25%
Biochemistry, Genetics and Molecular Biology
Preclinical Study
100%
Chromosome 11q
100%
Poly ADP Ribose Polymerase
100%
Small Molecule
50%
Clinical Trial
50%
Clinical Study
50%
Chromosomal Aberration
50%
Anticancer
50%
Hope
50%
Somatic Mutation
50%
Genomics
50%